amylin vs glp-1 What is the pipeline for future medications for obesity? 💡 𝗘𝘃𝗲𝗿𝘆𝗼𝗻𝗲'𝘀 𝘁𝗮𝗹𝗸𝗶𝗻𝗴 𝗮𝗯𝗼𝘂𝘁 𝗚𝗟𝗣-𝟭𝘀.

Saving tens of millions of children a year from the effects of lead poisoning is a surprisingly solvable problem

In a Phase 3 trial, orforglipron demonstrated a reduction in HbA1c levels by up to 1.6% and an average weight loss of 16 pounds over 40 weeks

and/or EU

Mice with adipose tissue-specific Bcat2 knockout showed resistance to high-fat diet-induced obesity, exhibiting enhanced browning of white adipose tissue and increased thermogenic capacity (111)

Good ones to ask include: Which compounding pharmacy fills your prescriptions

Two recent studies provide evidence that glutathione has a crucial role in the isomerization of nonnative disulphide bonds